Substance use disorders comorbid with mood and anxiety disorders in the Australian general population

被引:43
|
作者
Prior, Katrina [1 ,2 ]
Mills, Katherine [1 ,2 ]
Ross, Joanne [1 ,2 ]
Teesson, Maree [1 ,2 ]
机构
[1] Natl Hlth & Med Res Council, Ctr Res Excellence Mental Hlth & Subst Use, Sydney, NSW, Australia
[2] Univ New South Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia
基金
英国医学研究理事会;
关键词
comorbidity; substance use disorder; mood disorder; anxiety disorder; prevalence; NATIONAL EPIDEMIOLOGIC SURVEY; ALCOHOL-USE DISORDERS; SELF-MEDICATION HYPOTHESIS; DRUG-USE DISORDERS; MENTAL-HEALTH; UNITED-STATES; PSYCHIATRIC-DISORDERS; LIFETIME PREVALENCE; SUICIDE ATTEMPTS; SOCIAL PHOBIA;
D O I
10.1111/dar.12419
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction and AimsSubstance use disorders (SUDs) are common and frequently co-occur with mood and anxiety disorders. This paper provides a detailed analysis of patterns, prevalence and correlates of mood and anxiety disorders among those with a (i) pure SUD; (ii) SUD plus a mood or anxiety disorder (SUDs+1); and (iii) SUD plus a mood and anxiety disorder (SUDs+2). Design and MethodsData came from the 2007 National Survey of Mental Health and Wellbeing; a nationally representative household survey of 8841 Australians aged 16-85years. ResultsThe 12-month prevalence of SUDs was 5.1%. Of those with a 12-month SUD, 65% met the criteria for pure SUDs, 19% for SUDs+1 and 16% for SUDs+2. Major depression was the most common mood disorder in both comorbid groups. One-third of SUDs+1 experienced social phobia, while over half of SUDs+2 experienced generalised anxiety disorder. Compared with pure SUDs, SUDs+1 experienced two times more and SUDs+2 experienced over four times more days out of role in the preceding 30days. Both comorbid groups were more likely to experience severe levels of impairment. SUDs+2 were over 18 times more likely to experience suicidal thoughts in the same year. SUDs+1 were over three times and SUDs+2 were over 10 times more likely to have had one or more consultations with a health professional in the previous year. Discussions and ConclusionsThese findings highlight the complexities inherent with responding to and treating multiple comorbidities among substance users and emphasise the need for coordinated, cohesive responses from drug and alcohol treatment services.[Prior K, Mills K, Ross J, Teesson M. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population. Drug Alcohol Rev 2017;36:317-324]
引用
收藏
页码:317 / 324
页数:8
相关论文
共 50 条
  • [1] Pharmacotherapy of comorbid mood, anxiety, and substance use disorders
    Brady, KT
    Verduin, ML
    [J]. SUBSTANCE USE & MISUSE, 2005, 40 (13-14) : 2021 - 2041
  • [2] Onset and temporal sequencing of lifetime anxiety, mood and substance use disorders in the general population
    Slade, T.
    McEvoy, P. M.
    Chapman, C.
    Grove, R.
    Teesson, M.
    [J]. EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES, 2015, 24 (01) : 45 - 53
  • [3] Anxiety, Mood, and Substance Use Disorders in Parents of Children With Anxiety Disorders
    Alicia A. Hughes
    Jami M. Furr
    Erica D. Sood
    Andrea J. Barmish
    Philip C. Kendall
    [J]. Child Psychiatry and Human Development, 2009, 40 : 405 - 419
  • [4] Comorbid substance use and anxiety disorders in adolescents
    Deas-Nesmith, D
    Brady, KT
    Campbell, S
    [J]. JOURNAL OF PSYCHOPATHOLOGY AND BEHAVIORAL ASSESSMENT, 1998, 20 (02) : 139 - 148
  • [5] Comorbid Substance Use and Anxiety Disorders in Adolescents
    Deborah Deas-Nesmith
    Kathleen T. Brady
    Sallie Campbell
    [J]. Journal of Psychopathology and Behavioral Assessment, 1998, 20 : 139 - 148
  • [6] Anxiety, Mood, and Substance Use Disorders in Parents of Children With Anxiety Disorders
    Hughes, Alicia A.
    Furr, Jami M.
    Sood, Erica D.
    Barmish, Andrea J.
    Kendall, Philip C.
    [J]. CHILD PSYCHIATRY & HUMAN DEVELOPMENT, 2009, 40 (03) : 405 - 419
  • [7] Management of comorbid anxiety and substance use disorders
    Myrick, H
    Brady, K
    [J]. PSYCHIATRIC ANNALS, 2001, 31 (04) : 265 - 271
  • [8] Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders
    Hill, Kevin P.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (10): : 1070 - +
  • [9] The spectrum of substance use in mood and anxiety disorders
    Sbrana, A
    Bizzarri, JV
    Rucci, P
    Gonnelli, C
    Doria, MR
    Spagnolli, S
    Ravani, L
    Raimondi, F
    Dell'Osso, LD
    Cassano, GB
    [J]. COMPREHENSIVE PSYCHIATRY, 2005, 46 (01) : 6 - 13
  • [10] The effect of comorbid substance use disorders on treatment outcome for anxiety disorders
    McEvoy, Peter M.
    Shand, Fiona
    [J]. JOURNAL OF ANXIETY DISORDERS, 2008, 22 (06) : 1087 - 1098